Trial Profile
A Randomized Placebo Controlled Double Blind Two Period Cross-Over Study to Assess the Safety and Pharmacokinetics and Pharmacodynamics of Oral Dosages of 1-MNA, (A Hypolipidemic Agent) in Healthy Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 11 Nov 2014
Price :
$35
*
At a glance
- Drugs N-1-methylnicotinamide (Primary)
- Indications Hyperlipidaemia
- Focus Pharmacokinetics
- Sponsors Pharmena North America
- 11 Nov 2014 New trial record